We are international
Donate
• about myeloma TEXT SIZE   
   back

Spring 2004 Volume 5, Issue 10:
Education Initiative
The International Myeloma Foundation (IMF) and Millennium Pharmaceuticals, Inc., of Cambridge, MA, the developer of VELCADE® (bortezomib) for Injection, are collaborating on a national medical education program designed for oncology nurses.
04.26.04

Be the first to comment

 related articles